Catasys Inc. (NASDAQ:CATS) has been assigned a consensus broker rating score of 1.50 (Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. Catasys’ rating score has declined by 50% from three months ago as a result of a number of analysts’ ratings changes.

Brokerages have set a one year consensus price target of $10.00 for the company and are anticipating that the company will post ($0.13) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 198 out of 265 based on the ratings given to related companies.

Several brokerages have recently weighed in on CATS. Telsey Advisory Group began coverage on Catasys in a research report on Wednesday, October 18th. They issued a “buy” rating for the company. Zacks Investment Research upgraded Catasys from a “sell” rating to a “hold” rating in a research report on Monday, August 7th. Taglich Brothers began coverage on Catasys in a research report on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 price target for the company. Finally, ValuEngine cut Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st.

Hedge funds and other institutional investors have recently made changes to their positions in the company. UBS Oconnor LLC purchased a new position in shares of Catasys in the second quarter valued at $834,000. Bard Associates Inc. purchased a new position in Catasys during the second quarter worth about $1,012,000. Kennedy Capital Management Inc. purchased a new position in Catasys during the second quarter worth about $1,385,000. Finally, FNY Partners Fund LP purchased a new position in Catasys during the second quarter worth about $1,560,000. Institutional investors own 6.39% of the company’s stock.

Shares of Catasys (NASDAQ:CATS) opened at $3.52 on Friday. Catasys has a 52-week low of $3.34 and a 52-week high of $14.00.

COPYRIGHT VIOLATION WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/12/03/zacks-catasys-inc-cats-receives-average-recommendation-of-buy-from-analysts.html.

About Catasys

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.